Home > Insider Trading > Filing (0001209191-22-018484)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
742112	Invacare Corp	IVC	Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)	952680965

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1453022	Anthony Laplaca	One Invacare Way Elyria OH 44035	Sr. Vp And General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Acquisiton	2022-03-11	10,000	$1.49	98,382	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Shares	Employee Stock Option (Right to Buy)	$0.00			71,933	71,933	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
	71,933	71,933	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.475 to $1.51, inclusive. The reporting person undertakes to provide to Invacare Corporation, any security holder of Invacare Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
No transaction is being reported on this line. Reported on a previously filed Form 3, Form 4, or Form 5.
The reporting person holds previously reported options to buy 71,933 Common Shares (with tandem tax withholding rights) under the Invacare Corporation 2003 Performance Plan and the Invacare Corporation 2013 Equity Compensation Plan, granted in reliance upon the exemption provided by Rule 16b-3. These options were granted between August 14, 2012 and March 16, 2017, at exercise prices between $12.15 to $14.49 per share, will expire between August 14, 2022 and March 16, 2027, and became exercisable between September 30, 2013 and February 19, 2020. The balance reflects the expiration of options to buy 11,200 Common Shares on September 2, 2021.